United States · Investor

Charter Life Sciences

Last cheque observed Dec 2013. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series BSeries ASeries C

Cheques on record
0%of best year0cheques in 12 months, 18 on record
Since the last cheque4710days00hrs00min00sec
Median round$8.8MRounds led0 of 18Sole investor2 roundsExits2 from the portfolioMostly inUnited States, 100%
Pitch Charter Life Sciences

Charter Life Sciences highlights

  1. 01

    18 rounds on record

  2. 02

    Mostly Series B and Series A: 72% of its rounds

  3. 03

    Sole investor in 2 rounds, median $2.8M

  4. 04

    2 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first18 appearances

  1. 2013

    4 rounds

  2. Dec
    XlumenaSeries C · US · finsmes.com$25MWith 4 others
  3. Oct
    Amaranth MedicalSeries B · US · amaranthmedical.com$20MWith 3 others
  4. Jun
    Minimally invasive devicesSeries B · US · finsmes.com$2.5MWith 2 others
  5. Mar
    Minimally invasive devicesSeries B · US · finsmes.com$9.0MWith 1 other
  6. 2011

    1 round

  7. Apr
    XlumenaSeries B · US · pehub.com$7.0MWith 4 others
  8. 2010

    2 rounds

  9. Aug
    Great Lakes PharmaceuticalsSeries B · US · onbiovc.com$3.1MWith 3 others
  10. Apr
    CorepairSeries C · US · sec.gov$4.5MSole investor
  11. 2009

    2 rounds

  12. Nov
    CymaBay TherapeuticsVenture · US · metabolex.com$8.6MWith 11 others
  13. Oct
    InviragenSeries A · US · inviragen.com$15MWith 3 others
  14. 2008

    2 rounds

  15. Sept
    APT PharmaceuticalsSeries A · US · aptbio.com$32MWith 6 others
  16. Feb
    CorepairSeries B · US · sec.gov$1.2MSole investor
  17. 2007

    3 rounds

  18. Oct
    APT PharmaceuticalsSeries A · US$22MWith 3 others
  19. Aug
    Mirabilis MedicaSeries A · US$11MWith 4 others
  20. Aug
    KFx MedicalSeries B · US$10MWith 4 others
  21. 2006

    2 rounds

  22. Sept
    CoMentisSeries B · US$50MWith 4 others
  23. Jun
    BullhornSeries C · US · nevcfunding.blogspot.com$1.5MWith 1 other
  24. 2005

    1 round

  25. Aug
    KFx MedicalSeries A · US$6.2MWith 3 others
  26. 2001

    1 round

  27. Aug
    WhiteLight SystemsVenture · US$7.0MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

InviragenBought by Takeda PharmaceuticalUndisclosedMay 2013
WhiteLight SystemsBought by SunGardUndisclosedJan 2004

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Charter Life Sciences. A count of rooms they were both in, not a relationship either has claimed.

Arboretum VenturesVC firm3rounds togetherVersant VenturesVC firm3rounds togetherAperture Venture PartnersVC firm2rounds togetherAscent Biomedical VenturesVC firm2rounds togetherBio*One CapitalCorporate VC2rounds togetherCanaanVC firm2rounds togetherGreat Point PartnersPrivate equity2rounds togetherMB Venture PartnersVC firm2rounds togetherMontreux Growth PartnersVC firm2rounds togetherVivo VenturesVC firm2rounds together

Quick answers about Charter Life Sciences

What does Charter Life Sciences invest in?

Charter Life Sciences invests most often at Series B and Series A (72% of the rounds on record).

How active is Charter Life Sciences?

18 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2013.

How big are Charter Life Sciences's cheques?

The median round it joins is $8.8M.

Does Charter Life Sciences lead rounds?

Rarely, if at all: none of its 18 investments on record names it as the lead.

Where does Charter Life Sciences invest?

Most of the companies it backs are in the United States (100%).

Is Charter Life Sciences investing now?

No investments in the last 12 months; the latest was in Dec 2013.

Who does Charter Life Sciences invest alongside?

Most often Arboretum Ventures (3 rounds together), Versant Ventures (3 rounds together) and Aperture Venture Partners (2 rounds together).

What kind of investor is Charter Life Sciences?

Charter Life Sciences is a VC firm based in United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it